Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer (Q33336346)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer |
scientific article |
Statements
1 reference
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer (English)
1 reference
G P Stathopoulos
1 reference
D Mavroudis
1 reference
N Tsavaris
1 reference
C Kouroussis
1 reference
G Aravantinos
1 reference
S Agelaki
1 reference
S Kakolyris
1 reference
S K Rigatos
1 reference
S Karabekios
1 reference
V Georgoulias
1 reference
1 January 2001
1 reference
1 reference
Identifiers
1 reference